Prospect News: News for Pathfinder Cell Therapy, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with P > Issuers starting with P, PP only > All stories on Pathfinder Cell Therapy, Inc. > Stories on Pathfinder Cell Therapy, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Pathfinder Cell Therapy, Inc.

12/4/2015	PP	Pathfinder Cell Therapy takes in $50,000 through 6% loan financing
11/4/2015	PP	Pathfinder Cell Therapy raises $48,000 through its 6% loan financing
8/18/2015	PP	Pathfinder Cell Therapy takes in $59,000 through its 6% loan financing
7/20/2015	PP	Pathfinder Cell Therapy completes $75,000 6% loan financing agreement
6/10/2015	PP	Pathfinder Cell Therapy settles $42,000 6% loan financing agreement
3/6/2015	PP	Pathfinder Cell Therapy concludes $55,000 6% loan financing agreement
2/3/2015	PP	Pathfinder Cell Therapy completes $75,000 6% loan financing agreement
12/31/2014	PP	Pathfinder Cell Therapy concludes $50,000 6% loan financing agreement
10/28/2014	PP	Pathfinder Cell Therapy completes $35,000 6% loan financing agreement
9/26/2014	PP	Pathfinder Cell Therapy concludes $80,000 6% loan financing agreement
8/26/2014	PP	Pathfinder Cell Therapy completes $100,000 6% loan financing agreement
8/6/2014	PP	Pathfinder Cell Therapy raises $50,000 via 6% loan financing agreement
6/30/2014	PP	Pathfinder Cell Therapy takes in $50,000 via loan financing agreement
5/29/2014	PP	Pathfinder Cell Therapy raises $120,000 via loan financing agreement
4/25/2014	PP	Pathfinder Cell Therapy takes in $100,000 via loan financing agreement
3/28/2014	PP	Pathfinder Cell Therapy raises $105,000 via loan financing agreement
2/24/2014	PP	Pathfinder Cell Therapy obtains $120,000 via loan financing agreement
1/27/2014	PP	Pathfinder Cell Therapy raises $105,000 via loan financing agreement
12/23/2013	PP	Pathfinder Cell Therapy raises $125,000 via loan financing agreement
11/26/2013	PP	Pathfinder Cell Therapy raises $100,000 via loan financing agreement
10/24/2013	PP	Pathfinder Cell Therapy takes in $135,000 through 6% loan financing
9/30/2013	PP	Pathfinder Cell Therapy concludes $100,000 loan financing agreement
8/23/2013	PP	Pathfinder Cell Therapy completes $100,000 loan financing agreement
7/29/2013	PP	Pathfinder Cell Therapy completes $170,000 loan financing agreement
7/1/2013	PP	Pathfinder Cell Therapy concludes $150,000 loan financing agreement
5/29/2013	PP	Pathfinder Cell Therapy completes $250,000 loan financing agreement
4/4/2013	PP	Pathfinder Cell Therapy concludes $150,000 loan financing agreement
1/15/2013	PP	Pathfinder Cell Therapy completes $75,000 loan financing agreement
12/28/2012	PP	Pathfinder Cell Therapy concludes $60,000 loan financing agreement
12/7/2012	PP	Pathfinder Cell Therapy completes a $70,000 loan financing agreement
11/26/2012	PP	Pathfinder Cell Therapy takes in $70,000 via loan financing agreement
10/29/2012	PP	Pathfinder Cell Therapy raises $200,000 via loan financing agreement
10/4/2012	PP	Pathfinder Cell Therapy secures $200,000 via loan financing agreement
8/22/2012	PP	Pathfinder sells $100,000 convertible promissory note to investor
7/31/2012	PP	Pathfinder Cell Therapy wraps $50,000 placement of 6% convertible note
6/1/2012	PP	Pathfinder sells $270,000 convertible promissory note to investor

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.